Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical capsaicin for burning mouth syndrome
ACTRN12608000235303Phase 3Completed
- Sponsor
- University of São Paulo
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of capsaicin in glossodynia (BMS) (2 arms), sponsored by University of São Paulo. Primary endpoint: Relief of symptoms. Started Dec 2007; status: completed.
02
Drugs
capsaicin
03
Conditions
glossodynia (BMS)
Beyond the preview
Go deeper on ACTRN12608000235303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000235303.